Exosomes from bone marrow mesenchymal stem cells can alleviate early brain injury following subarachnoid hemorrhage through miRNA129-5p-HMGB1 pathway.
In this study, the roles of exosomes (Exo) from bone marrow mesenchymal stem cells in attenuating early brain injury (EBI) in rat brain after subarachnoid hemorrhage (SAH) had been investigated. The male Sprague-Dawley rats (300-350g) were used to establish the SAH model using endovascular perforation method. The animals were randomly divided into three groups: Sham (n=25), SAH+PBS(n=42) and SAH+Exo groups (n=33). At 1 hour after SAH, Exo or PBS was administered by femoral vein injection. The effects of Exo on the mortality, neurological function, brain water content and blood brain-barrier(BBB) were explored. Furthermore, the expressions of miRNA129-5p and high-mobility group box 1 protein (HMGB1) following Exo treatment was also detected. Additionally, immunohistochemistry and western blot were applied to investigate the mechanism of Exo's effects. The results indicated that Exo could improve the neurological functions, reduce brain water content and maintain BBB integrity after SAH. Following Exo treatment, the expression of miRNA129-5p was significantly increased, while the RNA level of HMGB1 was decreased. The protein levels of pro-inflammatory and pro-apoptosis factors, such as HMGB1, Toll-like receptor-4 (TLR-4), tumor necrosis factor-α (TNF-α), p53 were increased after SAH, which were significantly declined after Exo application. The results indicated that Exo from bone marrow mesenchymal stem cells could alleviate EBI following SAH through miRNA129-5p's anti-inflammation and anti-apoptosis effects via quenching the activity of HMGB1-TLR4 pathway.